The Mind Your Meds awareness campaign, targeted at patients and caregivers, shares insights on medication adherence and the pharmacy support systems available to help.
HRG reviewed nine products in the health category, 48 in the wellness sector and 32 items in the beauty aisle to see which ones stood out as Products to Watch.
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the United States, subject to regulatory approval, no later than Feb. 21, 2025.